Recently, Gironda et al. published a prospective pilot study of 32 patients with locally advanced esophageal cancer, including ESCC and EAC, in which they described the sequential presence of CAML during chemoradiotherapy 17. This evidence concerns the gene CAMLG and esophageal squamous cell carcinoma.